- Home
- IMCC vs AIMD Comparison
IMCC vs AIMD Comparison
Compare IMCC & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCC | AIMD |
|---|---|---|
| Founded | 1980 | 1984 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 10.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMCC | AIMD |
|---|---|---|
| Price | $1.42 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 276.1K | 25.8K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,606,703.00 | $113,037.00 |
| Revenue This Year | $47.12 | N/A |
| Revenue Next Year | $12.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.92 | ★ 178.19 |
| 52 Week Low | $0.93 | $1.78 |
| 52 Week High | $7.12 | $5.00 |
Technical Indicators
Market Signals| Indicator | IMCC | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.16 | 33.52 |
| Support Level | $1.33 | $1.94 |
| Resistance Level | $1.59 | $2.01 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 16.25 | 5.21 |
Price Performance
Historical ComparisonAbout IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.